Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_17676 | 73 | 1.53 | Mlig455_069399 | Neo: - Age: Up-Down-Down, logFC(26M/2M)=-0.674 Region-enriched R4: 3.236/0.00952 |
GLRA4 | Mlig455_069399 {REF} {Length: 2912} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=109.4]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=19.5]} {Human: ENSG00000188828, GLRA4, glycine receptor alpha 4, [Score=163, Expect=2e-46]; ENSG00000145451, GLRA3, glycine receptor alpha 3, [Score=159, Expect=1e-44]; ENSG00000101958, GLRA2, glycine receptor alpha 2, [Score=157, Expect=2e-44]; ENSG00000145888, GLRA1, glycine receptor alpha 1, [Score=155, Expect=7e-43]} {Mouse: ENSMUSG00000018595, Glra4, glycine receptor, alpha 4 subunit, [Score=164, Expect=2e-46]; ENSMUSG00000038257, Glra3, glycine receptor, alpha 3 subunit, [Score=160, Expect=6e-45]; ENSMUSG00000018589, Glra2, glycine receptor, alpha 2 subunit, [Score=157, Expect=6e-44]} {Dmel: FBgn0024963, GluClalpha, [Score=157, Expect=7e-44]} {Celegans: WBGene00000232, avr-14, Inhibitory amino acid receptor subunit gbr-2A, [Score=158, Expect=8e-45]} {Smed: dd_Smed_v6_10794_0_1, dd_Smed_v6_10794_0_1, [Score=177, Expect=2e-51]} {RNA1509_40602} {RNA1310_17891} {RNA815_35711} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | -4.488 | 1.759 | 0.99964 | 1.00000 | |
RegionR2 | 1.02 | 1.759 | 0.42693 | 0.81762 | |
RegionR3 | 1.412 | 1.759 | 0.23518 | 0.77670 | |
RegionR4 | 3.236 | 1.759 | 0.00089 | 0.00952 | |
RegionR5 | -1.203 | 1.759 | 0.95642 | 1.00000 | |
RegionR6 | 1.241 | 1.759 | 0.31429 | 0.90289 | |
RegionR7 | 2.626 | 1.759 | 0.03879 | 0.37799 | |
RegionR8 | -3.844 | 1.759 | 1.00000 | 1.00000 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | 0.326 | 1.759 | 0.99996 | 1.00000 | |
RegenerationR2 | -0.1 | 1.759 | 0.91720 | 1.00000 | |
RegenerationR3 | 0.771 | 1.759 | 0.35982 | 0.77652 | |
RegenerationR4 | -1.497 | 1.759 | 0.05151 | 0.36486 | |
RegenerationR5 | 1.805 | 1.759 | 0.08121 | 0.44275 | |
RegenerationR6 | 0.035 | 1.759 | 0.97469 | 1.00000 | |
RegenerationBL | -1.013 | 1.759 | 0.94235 | 1.00000 | |
RegenerationTP | 2.733 | 1.759 | 0.15944 | 0.58729 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_17676 | 73 | 1.53 | Mlig455_069399 | Neo: - Age: Up-Down-Down, logFC(26M/2M)=-0.674 Region-enriched R4: 3.236/0.00952 |
GLRA4 | 6 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | Mlig455_069399 {REF} {Length: 2912} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=109.4]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=19.5]} {Human: ENSG00000188828, GLRA4, glycine receptor alpha 4, [Score=163, Expect=2e-46]; ENSG00000145451, GLRA3, glycine receptor alpha 3, [Score=159, Expect=1e-44]; ENSG00000101958, GLRA2, glycine receptor alpha 2, [Score=157, Expect=2e-44]; ENSG00000145888, GLRA1, glycine receptor alpha 1, [Score=155, Expect=7e-43]} {Mouse: ENSMUSG00000018595, Glra4, glycine receptor, alpha 4 subunit, [Score=164, Expect=2e-46]; ENSMUSG00000038257, Glra3, glycine receptor, alpha 3 subunit, [Score=160, Expect=6e-45]; ENSMUSG00000018589, Glra2, glycine receptor, alpha 2 subunit, [Score=157, Expect=6e-44]} {Dmel: FBgn0024963, GluClalpha, [Score=157, Expect=7e-44]} {Celegans: WBGene00000232, avr-14, Inhibitory amino acid receptor subunit gbr-2A, [Score=158, Expect=8e-45]} {Smed: dd_Smed_v6_10794_0_1, dd_Smed_v6_10794_0_1, [Score=177, Expect=2e-51]} {RNA1509_40602} {RNA1310_17891} {RNA815_35711} |
2. | MligTC455_15252 | 70 | 1.47 | Mlig455_001617 | Neo: - Age: Down-Up-Up Region-enriched R6: 3.950/0.00456 |
0.958 | - | - | - | - | - | 0.958 | Mlig455_001617 {REF} {Length: 1513} {RNA1310_34191} {RNA815_46951} |